T1	PROC 61 64	PET
#1	AnnotatorNotes T1	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T2	CHEM 104 122	68Ga-DOTA-péptidos
#2	AnnotatorNotes T2	C5198083; 68Ga-DOTA-Peptide; Amino Acid, Peptide, or Protein · Indicator, Reagent, or Diagnostic Aid
T3	DISO 130 153	tumores neuroendocrinos
#3	AnnotatorNotes T3	C0206754; Neuroendocrine Tumors; Neoplastic Process
T4	PROC 250 253	PET
#4	AnnotatorNotes T4	C0032743; Positron-Emission Tomography; Diagnostic Procedure
T5	CHEM 268 286	68Ga-DOTA-péptidos
#5	AnnotatorNotes T5	C5198083; 68Ga-DOTA-Peptide; Amino Acid, Peptide, or Protein · Indicator, Reagent, or Diagnostic Aid
T6	DISO 294 317	tumores neuroendocrinos
#6	AnnotatorNotes T6	C0206754; Neuroendocrine Tumors; Neoplastic Process
T7	DISO 351 399	Tumores neuroendocrinos gastroenteropancreáticos
#7	AnnotatorNotes T7	C2930967; Gastro-enteropancreatic neuroendocrine tumor; Neoplastic Process
T8	CHEM 258 265	18F-FDG
#8	AnnotatorNotes T8	C0046056; Fluorodeoxyglucose F18; Indicator, Reagent, or Diagnostic Aid · Organic Chemical
T9	DISO 482 498	NET metastáticos
T10	ANAT 549 560	pancreático
#9	AnnotatorNotes T10	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T11	ANAT 605 616	pancreático
#10	AnnotatorNotes T11	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T12	PROC 990 1011	tratamiento sistémico
T13	CHEM 1016 1029	radiofármacos
#11	AnnotatorNotes T13	C1644726; radiopharmaceutical agent; Indicator, Reagent, or Diagnostic Aid
T14	DISO 1046 1071	Enfermedad de alto riesgo
T15	ANAT 1073 1087	cardiovascular
#12	AnnotatorNotes T15	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T16	ANAT 1089 1097	pulmonar
#13	AnnotatorNotes T16	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T17	DISO 1105 1124	Hepatopatía crónica
#14	AnnotatorNotes T17	C0341439; Chronic liver disease; Disease or Syndrome
T18	PROC 66 84	prueba radiológica
T19	ANAT 138 153	neuroendocrinos
#15	AnnotatorNotes T19	C0027912; Neurosecretory Systems; Body System
T20	ANAT 302 317	neuroendocrinos
#16	AnnotatorNotes T20	C0027912; Neurosecretory Systems; Body System
T21	ANAT 359 374	neuroendocrinos
#17	AnnotatorNotes T21	C0027912; Neurosecretory Systems; Body System
T22	DISO 808 827	NETs con metástasis
T23	CHEM 90 97	18F-FDG
#18	AnnotatorNotes T23	C0046056; Fluorodeoxyglucose F18; Indicator, Reagent, or Diagnostic Aid · Organic Chemical
T24	DISO 739 743	NETs
T25	ANAT 375 399	gastroenteropancreáticos
T26	PROC 710 734	consentimiento informado
#19	AnnotatorNotes T26	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T27	DISO 891 895	NETs
T28	Date 13 17	2018
T30	LIVB 468 477	pacientes
#20	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	LIVB 516 525	pacientes
#21	AnnotatorNotes T31	C0030705; Patients; Patient or Disabled Group
T32	LIVB 566 575	pacientes
#22	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T33	LIVB 655 664	Pacientes
#23	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	Age 665 674	> 18 años
T35	LIVB 679 688	Pacientes
#24	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	Duration 850 860	> 12 meses
T37	LIVB 955 964	Pacientes
#25	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	PHYS 1034 1042	Embarazo
#26	AnnotatorNotes T38	C0032961; Pregnancy; Organism Function
T40	Duration 1117 1124	crónica
#27	AnnotatorNotes T40	C0205191; chronic; Temporal Concept
T41	LIVB 429 450	población del estudio
#28	AnnotatorNotes T41	C2348561; Study Population (group); Population Group
A1	Status T12 History_of
A2	Status T13 History_of
#29	AnnotatorNotes T18	C0032743; Positron-Emission Tomography; Diagnostic Procedure
#30	AnnotatorNotes T24	C0206754; Neuroendocrine Tumors; Neoplastic Process
#31	AnnotatorNotes T27	C0206754; Neuroendocrine Tumors; Neoplastic Process
T29	CONC 832 849	Esperanza de vida
#32	AnnotatorNotes T29	C0023671; Life Expectancy; Group Attribute
R1	Has_Duration_or_Interval Arg1:T29 Arg2:T36	
T39	Quantifier_or_Qualifier 899 906	Grado 3
R2	Has_Quantifier_or_Qualifier Arg1:T27 Arg2:T39	
R3	Used_for Arg1:T13 Arg2:T12	
R4	Experiences Arg1:T37 Arg2:T12	
R5	Location_of Arg1:T15 Arg2:T14	
R6	Location_of Arg1:T16 Arg2:T14	
R7	Has_Duration_or_Interval Arg1:T17 Arg2:T40	
R8	Used_for Arg1:T23 Arg2:T1	
R9	Used_for Arg1:T2 Arg2:T1	
R10	Used_for Arg1:T23 Arg2:T18	
R11	Used_for Arg1:T2 Arg2:T18	
R12	Location_of Arg1:T19 Arg2:T3	
T42	Quantifier_or_Qualifier 154 163	avanzados
#33	AnnotatorNotes T42	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R15	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T42	
T43	Quantifier_or_Qualifier 318 327	avanzados
#34	AnnotatorNotes T43	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R16	Location_of Arg1:T20 Arg2:T6	
R17	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T43	
R18	Used_for Arg1:T8 Arg2:T4	
R19	Used_for Arg1:T5 Arg2:T4	
R21	Location_of Arg1:T21 Arg2:T7	
R22	Experiences Arg1:T30 Arg2:T9	
R23	Experiences Arg1:T41 Arg2:T9	
#35	AnnotatorNotes T9	C4744856; Metastatic Neuroendocrine Neoplasm; Neoplastic Process
T44	Quantifier_or_Qualifier 530 538	primario
#36	AnnotatorNotes T44	C0205225; Primary; Qualitative Concept
T45	Observation 542 548	origen
#37	AnnotatorNotes T45	C0475447; Site of primary tumor; Finding
R24	Location_of Arg1:T10 Arg2:T45	
R25	Has_Quantifier_or_Qualifier Arg1:T45 Arg2:T44	
R26	Experiences Arg1:T31 Arg2:T45	
T46	Observation 592 598	origen
#38	AnnotatorNotes T46	C0475447; Site of primary tumor; Finding
R27	Experiences Arg1:T32 Arg2:T46	
T47	Quantifier_or_Qualifier 580 588	primario
#39	AnnotatorNotes T47	C0205225; Primary; Qualitative Concept
R28	Has_Quantifier_or_Qualifier Arg1:T46 Arg2:T47	
T48	Quantifier_or_Qualifier 599 616	extra-pancreático
R29	Location_of Arg1:T48 Arg2:T46	
R30	Has_Age Arg1:T33 Arg2:T34	
T49	Quantifier_or_Qualifier 747 759	Grados 1 y 2
R31	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T49	
#40	AnnotatorNotes T22	C4744856; Metastatic Neuroendocrine Neoplasm; Neoplastic Process
#41	AnnotatorNotes T12	C1515119; Systemic Therapy; Therapeutic or Preventive Procedure
#42	AnnotatorNotes T39	C0443323; Third degree; Qualitative Concept
#43	AnnotatorNotes T49	C0441803; Grade 1/2; Intellectual Product
A3	Experiencer T37 Patient
A4	Experiencer T41 Patient
A5	Experiencer T30 Patient
A6	Experiencer T32 Patient
A7	Experiencer T33 Patient
A8	Experiencer T35 Patient
A9	Experiencer T31 Patient
